Faraz Ali - 17 Aug 2026 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: TNYA
Reported as of: 17 Aug 2026
Net transaction value: -$15,778
SEC form: 4
Accepted by SEC: 17 Aug 2026, 20:50:17 UTC
Prior SEC filing: 19 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact

Key filing fact

Faraz Ali filed Form 4 for Tenaya Therapeutics, Inc. (TNYA) on 17 Aug 2026.

Key facts

This page summarizes Faraz Ali's Form 4 filing for Tenaya Therapeutics, Inc. (TNYA).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 17 Aug 2026, 20:50.

Change

Previous filing in this sequence was filed on 19 May 2026.
Current net transaction value: -$15,778.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001667937 Primary reporting owner

Ali Faraz

Relationship: Chief Executive Officer, Director
Address: C/O TENAYA THERAPEUTICS, INC., 171 OYSTER POINT BLVD., 5TH FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Signature date: 17 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNYA transaction

Common Stock

Sale

Transaction value: $4,143
Shares: -5,837
Change %: -1.3%
Price: $0.7097
Shares after: 434,177
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

TNYA transaction

Common Stock

Sale

Transaction value: $2,817
Shares: -3,969
Change %: -0.91%
Price: $0.7098
Shares after: 430,208
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F2, F4, F5

TNYA transaction

Common Stock

Sale

Transaction value: $3,563
Shares: -5,020
Change %: -1.2%
Price: $0.7097
Shares after: 425,188
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F2, F6, F7

TNYA transaction

Common Stock

Sale

Transaction value: $5,256
Shares: -7,406
Change %: -1.7%
Price: $0.7097
Shares after: 417,782
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F2, F8, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.

Footnote F2

Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Footnote F3

Includes 305,956 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Footnote F4

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.

Footnote F5

Includes 295,331 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Footnote F6

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.

Footnote F7

Includes 281,894 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Footnote F8

Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.

Footnote F9

Includes 262,069 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.